Premium Nahrungsergänzungsmittel | artgerecht

Gilbert-Meulengracht Syndrome – Causes & Symptoms

Gilbert-Meulengracht Syndrome is a harmless, hereditary metabolic disorder of the liver causing mildly elevated bilirubin levels in the blood. It does not cause serious health problems.

Regular tips about health Regular tips about health

Things worth knowing about "Gilbert-Meulengracht Syndrome"

Gilbert-Meulengracht Syndrome is a harmless, hereditary metabolic disorder of the liver causing mildly elevated bilirubin levels in the blood. It does not cause serious health problems.

What is Gilbert-Meulengracht Syndrome?

Gilbert-Meulengracht Syndrome (also known as Gilbert Syndrome or simply Morbus Gilbert) is a benign, inherited metabolic condition affecting the liver. In this condition, the liver has a reduced ability to process bilirubin -- a yellow pigment produced during the normal breakdown of red blood cells. As a result, mildly elevated levels of bilirubin accumulate in the blood, which can occasionally cause a slight yellowing of the skin or the whites of the eyes (jaundice). The condition is common, affecting an estimated 5-10% of the general population.

Causes

Gilbert-Meulengracht Syndrome is caused by a genetic variant (mutation) in the UGT1A1 gene. This gene encodes the enzyme UDP-glucuronosyltransferase 1A1, which is responsible for converting indirect (unconjugated) bilirubin into a water-soluble form that can be excreted from the body. In affected individuals, the activity of this enzyme is reduced to approximately 30% of normal, leading to a mild buildup of unconjugated bilirubin in the bloodstream.

The condition is inherited in an autosomal recessive pattern, meaning that two copies of the altered gene are typically required for the syndrome to fully manifest. However, carrying just one copy of the mutation can also result in slightly elevated bilirubin levels.

Triggering Factors for Elevated Bilirubin

Certain situations can temporarily raise bilirubin levels further and trigger visible symptoms:

Fasting or skipping meals
Physical or emotional stress
Infections or fever
Alcohol consumption
Strenuous physical exercise
Sleep deprivation
Menstruation (in women)

Symptoms

In most cases, Gilbert-Meulengracht Syndrome causes no significant symptoms. The most common signs include:

Mild yellowing of the skin and/or eyes (jaundice), especially during fasting or times of stress
Occasional fatigue or general malaise
Rarely, abdominal discomfort or nausea

Symptoms are typically mild and temporary, and liver function remains fully intact.

Diagnosis

The condition is often discovered incidentally during routine blood tests. Characteristic findings include:

Mildly elevated total bilirubin (usually between 1.5 and 3.0 mg/dl), with normal direct bilirubin
Normal liver enzymes (ALT, AST, GGT, alkaline phosphatase)
Normal complete blood count

To rule out other conditions, a physician may order the following investigations:

Fractionation of direct and indirect bilirubin
Ultrasound of the liver and bile ducts
Genetic testing for the UGT1A1 mutation (in uncertain cases)

Distinguishing from Other Conditions

It is important to differentiate Gilbert-Meulengracht Syndrome from other causes of elevated bilirubin, such as hemolytic anemia (increased breakdown of red blood cells), hepatitis, liver cirrhosis, or gallstones.

Treatment

Gilbert-Meulengracht Syndrome is a benign condition that requires no specific treatment. Life expectancy and liver function are completely normal in affected individuals. The following lifestyle measures are recommended:

Regular meals and avoidance of prolonged fasting
Reduction of stress and adequate sleep
Moderate alcohol consumption
Awareness of potential drug interactions, as the UGT1A1 enzyme is also responsible for metabolizing certain medications (e.g., irinotecan, a chemotherapy drug)

Affected individuals should inform their healthcare provider of their diagnosis, so that caution can be exercised when prescribing certain medications.

Prognosis

The prognosis for Gilbert-Meulengracht Syndrome is excellent. The condition has no negative impact on overall health and does not require long-term medical treatment. Affected individuals can lead a completely normal life.

References

Strassburg CP. - Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Dubin-Johnson, and others). - Best Practice & Research Clinical Gastroenterology, 2010.
Bosma PJ et al. - The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. - New England Journal of Medicine, 1995.
National Institutes of Health (NIH) - MedlinePlus: Gilbert Disease. Available at: medlineplus.gov, 2023.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.